Generic placeholder image

Recent Patents on CNS Drug Discovery (Discontinued)


ISSN (Print): 1574-8898
ISSN (Online): 2212-3954

Therapeutic Approaches for Lysosomal Storage Diseases: A Patent Update

Author(s): Lorena Urbanelli, Krizia Sagini, Mario Polidoro, Alessandro Brozzi, Alessandro Magini and Carla Emiliani

Volume 8, Issue 2, 2013

Page: [91 - 109] Pages: 19

DOI: 10.2174/15748898113089990002

Price: $65


Lysosomal Storage Diseases (LSDs) are inherited metabolic disorders caused by specific lysosomal protein deficiencies, which lead to abnormal storage of macromolecular substrates. Most LSDs are characterized by central nervous system (CNS) pathology, intracellular deposition and protein aggregation, events also found in age-related neurodegenerative diseases. Over the past two decades, a few approaches for the cure of these disorders have been approved for clinical use, i.e. enzyme replacement therapy (ERT) and substrate reduction therapy (SRT). However, these treatments are hampered by major limitations, such as the poor biodistribution in the CNS for ERT and severe side effects for SRT. Several additional therapeutic strategies have been proposed. In particular clinical trials are ongoing based on enzyme enhancement by pharmacological chaperones, i.e. small molecule compounds able to increases the residual activity of the lysosomal enzyme, and gene therapy approaches. In addition, recent patents in the field provide evidence that many efforts are currently dedicated to i) improve the properties of enzymes used for ERT, ii) find new pharmacological chaperones without inhibitory effects on enzyme activity and iii) combine gene therapy approaches with genome editing methods.

Keywords: Autophagic-lysosomal system, lysosomal storage disorders, endosomal-lysosomal dysfunction, autophagy, gene therapy, cell-based therapy, enzyme replacement therapy, substrate reduction therapy, pharmacological chaperones, enzyme biodistribution, enzyme targeting, enhanced exocytosis therapy, cholesterol removal, proteostasis regulation, neurodegenerative diseases.

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy